KK
Kranti Kumar Singh
About Kranti Kumar Singh
Data last updated:
Kranti Kumar Singh is a Director at Uddanda Ally Private Limited (since 2018) and Director at Zorillo Pharmaceuticals Private Limited (since 2019). The companies operate in Trading and Chemicals. The largest current company by reported revenue is Uddanda Ally Private Limited at ₹8.1 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Uddanda Ally Private Limited U52110JH2018PTC011863 | Director | 19 Sep 2018 | 2018 | ₹8.1 Lakh (FY 2023) | Active |
| Zorillo Pharmaceuticals Private Limited U24239MP2019PTC048957 | Director | 24 Jun 2019 | 2019 | Active |
Board colleagues of Kranti Kumar Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sakshi Choubey | 08228949 | Uddanda Ally Private Limited | Director |
| Teena | 08491479 | Zorillo Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kranti Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kranti Kumar Singh
Kranti Kumar Singh currently holds 2 directorships: Uddanda Ally Private Limited (Director, since 19 Sep 2018, revenue ₹8.1 Lakh (FY 2023)); Zorillo Pharmaceuticals Private Limited (Director, since 24 Jun 2019).
Kranti Kumar Singh was first appointed on 19 Sep 2018 as Director at Uddanda Ally Private Limited. The most recent appointment on record is 24 Jun 2019 at Zorillo Pharmaceuticals Private Limited.
The current boards of Kranti Kumar Singh's companies include Sakshi Choubey (Uddanda Ally Private Limited), Teena (Zorillo Pharmaceuticals Private Limited).